CONTACT
+91 80 2808 2808
info@biocon.com
Biocon  /  Businesses  /  Biosimilars  /  Global Portfolio

BIOCON BIOSIMILARS

Biocon’s Global Biosimilars Portfolio

null

Biocon Biologics Presents #StoriesofHope: Kumudha Raju

Read our patient stories

Insulin Glargine: Making Effective Diabetes Management accessible to all!

More  

India’s first US FDA approved Biosimilar Trastuzumab brings new hope to patients

More  

Bevacizumab shows the way for affordable, accessible cancer care!

More  

#StoriesofHope

Biocon Biologics Presents #StoriesofHope: Mala S Rao

CORPORATE GOVERNANCE
KEY THERAPEUTIC AREAS
RESEARCH SERVICES
OUR CULTURE
RESPONSIBILITY
Share